Clinical Research Units White Papers & Case Studies
-
Regulatory Approval Of Clinical Studies In The Netherlands
5/16/2013
The EU Clinical Trials Directive (CTD) has been fully implemented in the Netherlands.
-
Human ADME & Studies With Radiolabeled Compounds
During clinical drug development there can be several situations where the use of radiolabeled medication or other radiolabeled compounds is required or favorable to accomplish the study objectives. This whitepaper is mainly focusing on human ADME studies and “microdose” studies to assess absolute bioavailability (BA). The major part of the information in this overview is also relevant for other clinical studies with a radiolabeled compound. By Ad Roffel and Henk Poelman, PRA Health Sciences
This website uses cookies to ensure you get the best experience on our website. Learn more